Cato Mørk

University of Wisconsin–Madison — United States

Immunology and Microbiology · Life Sciences

29h-index3.6kcitations90works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psoriasis: Treatment and Pathogenesis(15), Biosimilars and Bioanalytical Methods(15), Inflammatory Bowel Disease(11), Pain Mechanisms and Treatments(10), Dermatology and Skin Diseases(10)

Publications88 total

A MET-Targeted Variable New Antigen Receptor (VNAR) Theranostic for Non-Small Cell Lung Cancer
2026Open Access
Alopecia Areata: Impact on Patients’ Quality of Life and Disease Perception: A Survey-Based Study
Acta Dermato Venereologica·2025· 1 citedOpen Access
Abstract 1335: Comparison of X-ray and gamma-ray irradiators for in vitro and in vivo biological effectiveness
Cancer Research·2025
Abstract B026: Development of a novel theranostic agent targeting MET in lung and head and neck cancer
Clinical Cancer Research·2025
Genetic Variants in the SCN9A Gene are Detected in a Minority of Erythromelalgia Patients
Acta Dermato Venereologica·2025Open Access
Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer
Molecular Pharmaceutics·2024· 2 citedOpen Access
Evaluating the Efficacy of Novel MET-Targeting Camelid Derived Antibody as an Imaging Agent in Head and Neck Cancers
International Journal of Radiation Oncology*Biology*Physics·2024Open Access
Clinical versus Histological Assessment of Basal Cell Carcinoma Subtype and Thickness of Tumours Selected for Photodynamic Therapy
Acta Dermato Venereologica·2024· 2 citedOpen Access
New, simplified versus standard photodynamic therapy (PDT) regimen for superficial and nodular basal cell carcinoma (BCC): A single-blind, non-inferiority, randomised controlled multicentre study
PLoS ONE·2024· 6 citedOpen Access
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials
The Lancet Rheumatology·2024· 15 cited
OP0060 CLINICAL CONSEQUENCES OF INFLIXIMAB IMMUNOGENICITY AND THE IMPACT OF THERAPEUTIC DRUG MONITORING: SECONDARY ANALYSES OF A RANDOMISED CLINICAL TRIAL
Annals of the Rheumatic Diseases·2023· 3 citedOpen Access
HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases
Journal of Internal Medicine·2023· 9 citedOpen Access
Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
Journal of Internal Medicine·2022· 36 citedOpen Access
OP09 Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B study
Journal of Crohn s and Colitis·2022· 4 citedOpen Access
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases
JAMA·2021· 147 citedOpen Access
OP0301 RISK FACTORS FOR ANTI-INFLIXIMAB ANTIBODY FORMATION: RESULTS FROM THE RANDOMISED CONTROLLED NOR-DRUM A TRIAL
Annals of the Rheumatic Diseases·2021
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases
JAMA·2021· 117 citedOpen Access
OP0017 THERAPEUTIC DRUG MONITORING COMPARED TO STANDARD TREATMENT OF PATIENTS STARTING INFLIXIMAB THERAPY: RESULTS FROM A MULTICENTRE RANDOMISED TRIAL OF 400 PATIENTS
Annals of the Rheumatic Diseases·2020· 13 cited
Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
Trials·2020· 40 citedOpen Access
Infectious Pseudochromhidrosis: A Case Report and Literature Review
Acta Dermato Venereologica·2019· 12 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Guro Løvik Goll(13), Nils Bolstad(13), Espen A. Haavardsholm(13), Jørgen Jahnsen(13), Tore K Kvien(12), Kristin Kaasen Jørgensen(9), Inge Christoffer Olsen(9), David J. Warren(9), Knut Kvernebo(9), Øystein Sandanger(8), Marthe Kirkesæther Brun(7), Johanna Elin Gehin(7), Silje Watterdal Syversen(6), Joseph Sexton(6), Rolf Anton Klaasen(6), M Lorentzen(5), Ingrid Marianne Blomgren(5), Geir Noraberg(5), Kathrine Aglen Seeberg(5), Roald Torp(5)